| Literature DB >> 35526066 |
Estelle Moulin1,2, Noémie Boillat-Blanco3, Giorgio Zanetti4, Catherine Plüss-Suard5, Serge de Vallière3, Laurence Senn4,3.
Abstract
BACKGROUND: The growing threat of multidrug resistant organisms have led to increasingly promote prudent and rational use of antimicrobials as well as early hospital discharge plan. Antibiotic stewardship programs (ASP) have been developed as multifaceted approaches to improve use of current antibiotics and are now widely applied through different strategies. Proactive interventions are still limited in Switzerland and data on antimicrobial appropriateness and early discharge strategies are lacking. We aimed to describe the opportunities of antibiotics prescriptions optimization at Lausanne University Hospital, Switzerland and evaluate the suitability for early discharge among patients receiving antibiotics. The need for outpatient medical structures was also assessed.Entities:
Keywords: Antibiotic stewardship programs; Early discharge; Outpatient parenteral therapy
Mesh:
Substances:
Year: 2022 PMID: 35526066 PMCID: PMC9080203 DOI: 10.1186/s13756-022-01104-z
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 6.454
Fig. 1Flow chart used to assess the appropriateness of antimicrobial prescriptions
Characteristics of patients receiving systemic antimicrobial treatment, n (%)
| Study population n = 120 | |
|---|---|
| Age (years, median, IQR) | 71 (54–83) |
| Sex (M/F) | 68/52 |
| Medical | 48 (40.0%) |
| Surgical | 72 (60.0%) |
| Comorbidities | 114 (95.0%) |
| Heart diseases | 40 (33.3%) |
| Diabetes | 31 (25.8%) |
| Neurological diseases | 28 (23.3%) |
| Respiratory diseases | 27 (22.5%) |
| Chronic kidney disease | 25 (20.8%) |
| Immunosuppression | 53 (44.2%) |
| Solid organ transplant | 3 (2.5%) |
| Solid malignancies | 34 (28.3%) |
| Hematological malignancies | 11 (9.2%) |
| Autoimmune diseases | 9 (7.5%) |
| Antibiotic allergy | 12 (10.0%) |
| Penicillin | 4 (3.3%) |
| Cephalosporin | 2 (1.7%) |
| Sulfamide | 1 (0.8%) |
| At least one nosocomial infection | 43 (35.8%) |
| At least one episode of fever of unknown origin | 5 (4.2%) |
| At least one clinically documented infection | 43 (35.8%) |
| At least one microbiologically documented infection | 67 (55.8%) |
| Lungs | 28 (23.3%) |
| Abdomen | 23 (19.2%) |
| Bone and joints | 20 (16.7%) |
| Urinary tract | 18 (15.0%) |
| Surgical site | 11 (9.2%) |
| Endocarditis | 6 (5.0%) |
| Soft tissues | 5 (4.2%) |
| Primary bacteremia | 4 (3.3%) |
| Catheter | 2 (1.7%) |
| At least one prior consultation by an ID specialist | 55 (45.8%) |
| Amoxicillin-clavulanate | 32 (26.7%) |
| Piperacillin-tazobactam | 25 (20.8%) |
| First-to third-generation cephalosporins | 19 (15.8%) |
| Co-trimoxazole | 19 (15.8%) |
| Vancomycin | 17 (14.2%) |
| Other penicillins | 12 (10.0%) |
| Carbapenems | 12 (10.0%) |
| Quinolones | 8 (6.7%) |
| Metronidazole | 8 (6.7%) |
| Macrolides | 3 (2.5%) |
* A total of 151 antibiotic prescriptions were recorded as patients could receive combined therapies
Fig. 2Results of the assessment of systemic antimicrobial treatments and suitability of early discharge